Biotech entity
Every one of those 1 sits in a single category, fda-approval. DIAGNOS Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Arm's-length lenders, all published on June 21, 2026.
Last mentioned: Jun 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, fda-approval. DIAGNOS Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Arm's-length lenders, all published on June 21, 2026. Each carries 4 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Arm's-length lenders. Shared-story counts are live from our verified record — not editorial picks.
Share Hold Period Expires
Four-month-and-one-day hold period ends, allowing newly issued shares to be freely traded, subject to securities laws.
Anticipated Settlement Date
Settlement expected to close, with 625,000 shares issued and accrued interest paid in cash.
Debt-for-Equity Agreements Signed
DIAGNOS signs agreements with two lenders to settle C$125,000 in demand loans via equity issuance.
Biotech company DIAGNOS executes a small debt-for-equity swap, preserving liquidity to sustain its AI-based early detection platform for critical eye conditions. The move reflects the tight capital environment for early-stage diagnostic innovators.
Arm's-length lenders is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
